They postulated that increased NKG2D expression could be a reaction to the enlarged hepatocyte stress, inflammation, and gut microbiota-derived signals observed in NASH patients [52]. The gene discussed is KLRK1; the disease is metabolic dysfunction-associated steatohepatitis.